Search for: "DAY v. USA"
Results 521 - 540
of 2,774
Sorted by Relevance
|
Sort by Date
6 Jan 2012, 10:34 am
In Guzzo v Cristofano, 2011 WL 6934108 (S.D.N.Y.) [read post]
23 May 2008, 10:17 pm
Philip Morris USA, Inc., 142 P.3d 1079 (Or. [read post]
18 Dec 2008, 11:00 pm
Vasquez v. [read post]
18 Mar 2008, 5:00 pm
The case, Harmony at Madrona Park Owners Assoc. v. [read post]
23 Aug 2010, 7:04 am
A July 27, 2010 decision by the United States Court of Appeals for the Third Circuit, in Bimbo Bakeries USA, Inc. v. [read post]
20 Mar 2012, 6:50 am
Reuters presents a video interview with Justice Sandra Day O’ Connor. [read post]
27 Feb 2008, 12:11 am
I read the latest filing by the special prosecutors in USA v. [read post]
15 Oct 2007, 7:28 pm
After seven days of trial, a Central District of California jury found on Oct. 11 that plaintiff/counterclaim defendant SLB Toys USA, Inc., had diluted defendant/ counterclaim plaintiff Wham-O, Inc. [read post]
11 Jan 2021, 8:17 am
On Dec. 1, 2020, the Supreme Court heard oral arguments in Nestlé USA, Inc. v. [read post]
9 Jan 2018, 4:32 am
For USA Today, Richard Wolf reports that in Tharpe v. [read post]
15 May 2019, 12:56 pm
Circuit’s decision in United States v. [read post]
26 Feb 2013, 6:17 pm
Amnesty International USA this morning. [read post]
17 Aug 2015, 1:38 pm
Nestle USA Inc., No. 3:15-cv-01963 (N.D. [read post]
10 Dec 2015, 7:08 am
HSBC Bank USA, N.A. [read post]
1 Oct 2018, 2:14 pm
This could cost Canada more than $450 million a year and most of this would be outflows to the USA. [read post]
27 Oct 2017, 11:43 am
., San Francisco, CA 94109, USA. [read post]
4 Jan 2023, 10:00 pm
# # #Royalty Only and Odell Cornelius Beckham, Jr. v Nike USA, Inc. [read post]
25 Mar 2024, 10:22 am
Marina Pitofsky of USA Today reports that “Former Justice Stephen Breyer says he has ‘theories’ about who leaked opinion overturning Roe v. [read post]
9 Mar 2015, 2:03 pm
[Legal Cheek] * King v. [read post]
25 May 2017, 6:20 pm
A post concerning future generic "Copaxone" at raps.org beginsGeneric versions of Teva's multi-billion-dollar per year multiple sclerosis drug Copaxone (glatiramer) are coming, but a closer look at which competitor might win the coveted 180-day exclusivity for its generic reveals an unusual and complex situation.Back in January, a US District Court for the District of Delaware ruling invalidated all asserted claims on Teva's patents on its 40mg version of Copaxone,… [read post]
